Cargando…

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases

Detalles Bibliográficos
Autores principales:	Zhang, Rui, He, Yang-Yang, Jing, Zhi-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225275/ https://www.ncbi.nlm.nih.gov/pubmed/32457632 http://dx.doi.org/10.3389/fphar.2020.00660

Ejemplares similares

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Data mining and network-driven analysis: Drug discovery and mechanism exploration by targeting vascular dysfunction
por: Dai, Zhao, et al.
Publicado: (2022)

Editorial: Targeted drug discovery in ectopic calcification: mechanism, prospect, and clinical application
por: Xu, Kang, et al.
Publicado: (2023)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
por: Zhao, Fan, et al.
Publicado: (2022)

Targeting pulmonary vascular endothelial cells for the treatment of respiratory diseases
por: Li, Yi-Xuan, et al.
Publicado: (2022)

Editorial: Antimycobacterial drug discovery: molecular therapeutics and target identification, Volume II
por: Gunosewoyo, Hendra, et al.
Publicado: (2023)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Synthetic Biology Speeds Up Drug Target Discovery
por: Xie, Yixuan, et al.
Publicado: (2020)

Editorial: Microfluidics and mass spectrometry in drug discovery and development: from synthesis to evaluation
por: Caruso, Giuseppe
Publicado: (2023)

Editorial: Ethnopharmacological Strategies for Drug Discovery Against African Neglected Diseases
por: Igoli, John O., et al.
Publicado: (2022)

Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases
por: Shao, Zhuo, et al.
Publicado: (2021)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
por: Biber, Knut, et al.
Publicado: (2019)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Editorial: Women in experimental pharmacology and drug discovery: 2021
por: Rižner, Tea Lanišnik, et al.
Publicado: (2022)

Editorial: Insights in experimental pharmacology and drug discovery: 2022
por: Latini, Alexandra, et al.
Publicado: (2023)

Editorial: Vascular smooth muscle cell fate and vascular remodeling: Mechanisms, therapeutic targets, and drugs, volume I
por: Wang, Qilong, et al.
Publicado: (2022)

Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
por: Liu, Linsheng
Publicado: (2022)

Editorial: Targeting pumps, channels and transporters for the treatments of vascular, cardiovascular and kidney diseases
por: Zhang, Jinwei, et al.
Publicado: (2023)

Editorial: Emerging and old viral diseases: Antiviral drug discovery from medicinal plants
por: Rahmatullah, Mohammed, et al.
Publicado: (2022)

Editorial: Methods and application in experimental pharmacology and drug discovery: 2021
por: Polito, Letizia, et al.
Publicado: (2022)

Editorial: Metabolomics as a tool in ethnobotany-driven drug discoveries
por: Makunga, Nokwanda, et al.
Publicado: (2022)

Editorial: Model organisms in experimental pharmacology and drug discovery 2022
por: Nainu, Firzan, et al.
Publicado: (2023)

Editorial: Spotlight on artificial intelligence in experimental pharmacology and drug discovery
por: Schöning, Verena, et al.
Publicado: (2023)

New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?
por: Du, Peixin, et al.
Publicado: (2022)

Editorial: Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery
por: Rižner, Tea Lanišnik
Publicado: (2019)

Editorial: Computational chemogenomics: In silico tools in pharmacological research and drug discovery
por: Sánchez-Cruz, Norberto, et al.
Publicado: (2023)

Editorial: Brief research reports in experimental pharmacology and drug discovery: 2022
por: Hassan, Tahsin, et al.
Publicado: (2023)

Editorial: Targeting Neuro-Immuno-Vascular Interactions in the Brain and the Periphery
por: Wilhelm, Imola, et al.
Publicado: (2022)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Editorial: Treatment of Alzheimer’s disease-discovery of natural products based on neurite outgrowth and neuroprotection
por: Yang, Zhiyou, et al.
Publicado: (2022)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
por: Wang, Zhi-Bin, et al.
Publicado: (2023)

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery
por: Wang, Xiaobo, et al.
Publicado: (2021)

The Grand Challenges in Cardiovascular Drug Discovery and Development
por: Ohlstein, Eliot H.
Publicado: (2010)

Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery
por: Sunildutt, Naina, et al.
Publicado: (2023)

Target-specific compound selectivity for multi-target drug discovery and repurposing
por: Wang, Tianduanyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7s8jqp7ck3g99uvhrggsf03n38